etoposide has been researched along with tr 14035 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amo, S; Bargatze, RF; Benson, E; Cao, J; De Laszlo, SE; Detmers, PA; Egger, LA; Hagmann, WK; Kidambi, U; Kopka, IE; Lanza, T; Lin, LS; Lingham, R; McCauley, E; Mumford, RA; Pikounis, B; Schmidt, JA; Tong, S; Van Riper, G; Warwood, S; Young, DN | 1 |
1 other study(ies) available for etoposide and tr 14035
| Article | Year |
|---|---|
Alpha(4)beta(7)/alpha(4)beta(1) dual integrin antagonists block alpha(4)beta(7)-dependent adhesion under shear flow.
Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Adhesion Molecules; Cyclophosphamide; Doxorubicin; Endothelium, Vascular; Etoposide; Female; Flow Cytometry; Humans; Immunoglobulin G; Immunoglobulins; Integrin alpha4beta1; Integrins; Ligands; Lymphocytes; Methotrexate; Mice; Mice, Inbred BALB C; Mucoproteins; Peyer's Patches; Phenylalanine; Receptors, Lymphocyte Homing; Recombinant Fusion Proteins; Rheology | 2002 |